CCIA
CGEM icon

Campbell & Co Investment Adviser’s Cullinan Oncology CGEM Stock Holding History

Campbell & Co Investment Adviser’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$202K Buy
+11,090
New +$165K 0.01% 978

Other funds holding CGEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TFCP
Twin Focus Capital Partners Boston, Massachusetts $983M AUM 37.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Campbell & Co Investment Adviser's CGEM Position: Q2 2026 in Review

Campbell & Co Investment Adviser opened a new position in Cullinan Oncology (CGEM) in Q2 2026: 11,090 shares worth $202K. The stake represents 0.01% of the portfolio and ranks #978 among its holdings.

50 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Campbell & Co Investment Adviser held 11,090 shares of Cullinan Oncology worth $202K as of Q2 2026.
  • Cullinan Oncology was a new Campbell & Co Investment Adviser position in Q2 2026.
  • Cullinan Oncology made up 0.01% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #978 holding.
  • 50 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.